Second Edition High-Throughput Screening by Cytometry Handbook: A Guide to Workflows and Assays
Laboratories developing next-generation therapeutics, face immense pressure to screen increasing numbers of compounds and libraries, often with limited sample volumes and without specialized expertise. The use of more complex cell models, such as stem cells, cell therapies, and patient-specific material, adds another layer of complexity, requiring more sophisticated analysis.
Modern bioanalytical technologies, including high-throughput screening (HTS) cytometry, are meeting this need. Our easy-to-use digital handbook is a comprehensive resource about the unique capabilities of HTS cytometry. Learn how routine workflows can benefit from the speed, throughput, and ease of use offered by the iQue® HTS by Cytometry Platform.
Easily navigate to topics of interest, informative workflow illustrations, detailed application examples, and direct links to external resources. Learn about multiplexed analysis of cell phenotype and secreted proteins in popular and emerging applications. Stay current on the latest reagents, assay kits, and software releases.
- Document type: Digital eBook / PDF / 26 MB
- Page count: 177
- Read time: 14 hours
Complete the form to access the Handbook
Second Edition High-Throughput Screening by Cytometry Handbook: Sections
- Cell Health
- Secreted Proteins
- Cell Line Development
- Biologics Discovery
- Immune Cell Models
- Cell Therapy
- Proliferation and Encoding Dyes
- Viability Assays
- Cell Cycle Assessment
- Apoptosis and Cytotoxicity Assays
- Viable Cell Count
- Titer and Viability Determination
- Hybridoma Screening
- Antibody Discovery
- Antibody Binding
- Antibody Internalization (ABI)
- Antibody-Dependent Cellular Cytotoxicity (ADCC)
- Antibody-Dependent Cellular Phagocytosis (ADCP)
- Complement-Dependent Cytotoxicity (CDC)
- Biosimilars
- Antibody Cytotoxicity
- Bispecific Antibodies
- T Cell Activation
- T Cell Killing
- T Cell Exhaustion
- T Cell Memory
- Mixed Lymphocyte Reaction (MLR)
- Natural Killer Cells
- Induced Pluripotent Stem Cells (iPSC) Maintenance and Differentiation
- Chimeric Antigen Receptor (CAR-T) Cells
- Advanced Cell Models
- T Cell Killing of Tumor Cells in Advanced 3D Cell Models
- Tumor Infiltrating Lymphocytes
- Organoids